Literature DB >> 8688078

Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein.

C Desbois1, R Rousset, F Bantignies, P Jalinot.   

Abstract

The Tax transactivator of the human T cell leukemia virus type I (HTLV-I) exhibits oncogenic properties. A screen for proteins interacting with Tax yielded a complementary DNA (cDNA) encoding the human Int-6 protein. In mice, the Int-6 gene can be converted into a putative dominant negative oncogene after retroviral insertion. Here, Int-6 was localized in the cell nucleus to give a speckled staining pattern superposed to that of the promyelocytic leukemia (PML) protein. The binding of Tax to Int-6 caused its redistribution from the nuclear domains to the cytoplasm. Thus, Int-6 is a component of the PML nuclear bodies and Tax disrupts its normal cellular localization by binding to it.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8688078     DOI: 10.1126/science.273.5277.951

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  48 in total

1.  Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption.

Authors:  S Müller; A Dejean
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Sum1, a component of the fission yeast eIF3 translation initiation complex, is rapidly relocalized during environmental stress and interacts with components of the 26S proteasome.

Authors:  Isabelle Dunand-Sauthier; Carol Walker; Caroline Wilkinson; Colin Gordon; Richard Crane; Chris Norbury; Tim Humphrey
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

3.  INT6 interacts with MIF4GD/SLIP1 and is necessary for efficient histone mRNA translation.

Authors:  Julia Neusiedler; Vincent Mocquet; Taran Limousin; Theophile Ohlmann; Christelle Morris; Pierre Jalinot
Journal:  RNA       Date:  2012-04-24       Impact factor: 4.942

Review 4.  Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies.

Authors:  M Hodges; C Tissot; K Howe; D Grimwade; P S Freemont
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

5.  The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein.

Authors:  M Alcalay; L Tomassoni; E Colombo; S Stoldt; F Grignani; M Fagioli; L Szekely; K Helin; P G Pelicci
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

6.  Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.

Authors:  P Dhordain; O Albagli; R J Lin; S Ansieau; S Quief; A Leutz; J P Kerckaert; R M Evans; D Leprince
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

7.  HTLV-I Tax self-association in optimal trans-activation function.

Authors:  D Y Jin; K T Jeang
Journal:  Nucleic Acids Res       Date:  1997-01-15       Impact factor: 16.971

8.  Characterization of the interaction between the interferon-induced protein P56 and the Int6 protein encoded by a locus of insertion of the mouse mammary tumor virus.

Authors:  J Guo; G C Sen
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 9.  Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies.

Authors:  Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

Review 10.  Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors.

Authors:  Li Chen; Alexander Endler; Futoshi Shibasaki
Journal:  Exp Mol Med       Date:  2009-12-31       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.